OTX-015 50mg | ≥99%
CSNpharm
OTX-015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM for BRD2, BRD3, and BRD4 in cell-free assays.
More Information Supplier PageOTX-015
Search Results
OTX-015 2mg | ≥99%
CSNpharm
OTX-015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM for BRD2, BRD3, and BRD4 in cell-free assays.
More Information Supplier PageOTX-015
OTX-015 5mg | ≥99%
CSNpharm
OTX-015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM for BRD2, BRD3, and BRD4 in cell-free assays.
More Information Supplier PageOTX-015
Ticlopidine HCl 250mg | ≥99%
CSNpharm
Ticlopidine HCl is an adenosine diphosphate (ADP) receptor inhibitor that against platelet aggregation with IC50 of ~2 μM.
More Information Supplier PageTiclopidine HCl
Ticlopidine HCl 1g | ≥99%
CSNpharm
Ticlopidine HCl is an adenosine diphosphate (ADP) receptor inhibitor that against platelet aggregation with IC50 of ~2 μM.
More Information Supplier PageTiclopidine HCl
AG-490 250mg | ≥99%
CSNpharm
AG-490 is a broad-spectrum inhibitor that has several targets including EGFR (IC50 = 2 μM), ErbB2 (IC50 = 13.5 μM), STAT3 and JAK2.
More Information Supplier PageAG-490
AG-490 10mg | ≥99%
CSNpharm
AG-490 is a broad-spectrum inhibitor that has several targets including EGFR (IC50 = 2 μM), ErbB2 (IC50 = 13.5 μM), STAT3 and JAK2.
More Information Supplier PageAG-490
AG-490 100mg | ≥99%
CSNpharm
AG-490 is a broad-spectrum inhibitor that has several targets including EGFR (IC50 = 2 μM), ErbB2 (IC50 = 13.5 μM), STAT3 and JAK2.
More Information Supplier PageAG-490
AG-490 50mg | ≥99%
CSNpharm
AG-490 is a broad-spectrum inhibitor that has several targets including EGFR (IC50 = 2 μM), ErbB2 (IC50 = 13.5 μM), STAT3 and JAK2.
More Information Supplier PageAG-490
MMAF 10mg | ≥99%
CSNpharm
MMAF can inhibit tubulin polymerization used in ADCs, with lower cytotoxic activity than MMAE.
More Information Supplier PageMMAF
